Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

Researchers found frequent reports of infective pulmonary exacerbation among ... world studies to establish benefits in people with cystic fibrosis with these variants,” Keating and colleagues ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting ... While advancements like Trikafta have significantly ...

In a report released on January 24, Joseph Schwartz from Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a ...

Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to ...

Rein Therapeutics (NASDAQ:RNTX) received a Buy rating from Rodman & Renshaw, with a newly established price target of $8.00. The firm began its coverage of the biotech company, highlighting its focus ...

The Milligans were sent off on their trip by Georgia Strait Towing, which helps volunteer and fundraise for Help Fill a Dream ...

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...